Califf: Sponsors Should Go Beyond Letter Of Law With Trial Diversity Plans
The FDA Commissioner wants sponsors to incorporate diversity into their development programs prior to Phase III.
The FDA Commissioner wants sponsors to incorporate diversity into their development programs prior to Phase III.